Epiontis possesses intellectual property and expertise in exploiting epigenetic information to enable regenerative medicine. To our partners, we provide this technological potential as focused products:
EpiTest – tests the identity and quality of cell preparations
EpiScreen – identifies novel growth factors in high throughput.